Expansive comments to CMS demonstrate that success of healthcare transformation relies on removing barriers to pharmacy care
As the Centers for Medicare & Medicaid Services studies the treatment and prevention of opioid addiction, NACDS has submitted comments on addressing the epidemic and caring for pain sufferers.
In comments to CMS, NACDS says weakening of state access standards is flawed policymaking, and threatens to harm patient health and increase Medicaid costs
NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.
Morning Consult today published an opinion piece by the NACDS entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.”
NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”
